Publications by authors named "Michael Egan"

Claim this Profile
N
Non-visual light modulates behavioral memory and gene expression in .
Zhijian Ji, Bingying Wang, Rashmi Chandra, Junqiang Liu, Supeng Yang, Michael Egan

bioRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 study.
Robert W Frenck, Abdi Naficy, Jodi Feser, Michelle P Dickey, Victor H Leyva-Grado, Michael A Egan

Lancet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling amyloid plaque turnover dynamics improves characterization of drug effects.
Eline van Maanen, Seth Robey, Idriss Bennacef, Stephen Duffull, Michael F Egan

Alzheimers Dement (N Y)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When, where, and how prey pair antipredator behaviors to natural and anthropogenic mortality risks.
Michael E Egan, Abigail M Weber, Nicole Gorman, Michael W Eichholz, Daniel Skinner

Mov Ecol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prepartum supplementation of dairy cows with inorganic selenium, organic selenium or rumen-protected choline does not affect carotenoid composition or colour characteristics of bovine colostrum or transition milk.
Fionnuala McDermott, Hao Shi, Emer Kennedy, Sean A Hogan, Lorraine Brennan, Michael Egan

J Dairy Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial.
Yuki Mukai, Robert Lupinacci, Stephen Marder, Linda Snow-Adami, Tiffini Voss, Michael F Egan

Schizophr Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating encounter-habitat relationships with scale-integrated resource selection functions.
Michael E Egan, Nicole T Gorman, Storm Crews, Michael W Eichholz, Dan Skinner

J Anim Ecol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119.
Spyros A Kalams, Barbara K Felber, James I Mullins, Hyman M Scott, Mary A Allen, Michael A Egan

JCI Insight· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracheobronchomalacia: an unusual cause of debilitating dyspnoea and its surgical management.
Kathryn Mulryan, James O'Connor, Michael Egan, Karen Redmond

BMJ Case Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioral responses of terrestrial mammals to COVID-19 lockdowns.
Marlee A Tucker, Aafke M Schipper, Tempe S F Adams, Nina Attias, Tal Avgar, Michael Egan, Shannon P Finnegan

Science· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-operative ureteral injury after cytoreductive surgery for ovarian cancer managed by primary repair through minimally invasive approach.
Danial Safavi, Vikkineshwaran Siva Subramaniam, Nedaa Obeidi, Michael Egan, Feras Abu Saadeh

Int J Gynecol Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.
Gregory J Wilson, Benigno Rodriguez, Shuying Sue Li, Mary Allen, Ian Frank, Michael Egan

Vaccine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.
Tiffini Voss, James Kost, Swati Pal Mercer, Christine Furtek, Christopher Randolph, Michael F Egan

J Alzheimers Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of F-flutemetamol amyloid PET image analysis parameters on the effect of verubecestat on brain amlyoid load in Alzheimer's disease.
Cyrille Sur, Katarzyna Adamczuk, David Scott, James Kost, Mehul Sampat, Michael F Egan

Mol Imaging Biol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An introduction to the Marburg virus vaccine consortium, MARVAC.
Robert W Cross, Ira M Longini, Stephan Becker, Karin Bok, David Boucher, Michael A Egan

PLoS Pathog· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine.
Isamu Tsuji, David Dominguez, Michael A Egan, Hansi J Dean

J Infect Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
Courtney Woolsey, Robert W Cross, Krystle N Agans, Viktoriya Borisevich, Daniel J Deer, Michael A Egan

PLoS Negl Trop Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Model-Based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verubecestat Trials.
Marissa F Dockendorf, David Jaworowicz, Rebecca Humphrey, Melanie Anderson, Sheila Breidinger, Michael F Egan

AAPS J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting.
Vianney Tricou, Raphael Gottardo, Michael A Egan, Frédéric Clement, Geert Leroux-Roels

Vaccine· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal Optical Coherence Tomography Metrics Are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy.
Robert C Sergott, Annaswamy Raji, James Kost, Cyrille Sur, Saheeda Jackson, Michael F Egan

J Alzheimers Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses.
John H Eldridge, Michael A Egan, Demetrius Matassov, Stefan Hamm, Luz Hermida

Vaccine· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From airway 'grading' to 'coding'.
Karthikeyan Srinivasan, Michael Egan

Eur J Anaesthesiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
Cyrille Sur, James Kost, David Scott, Katarzyna Adamczuk, Nick C Fox, Michael F Egan

Brain· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease.
Alette M Wessels, Christopher Lines, Robert A Stern, James Kost, Tiffini Voss, Michael F Egan

Alzheimers Dement· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial.
David K Clarke, Rong Xu, Demetrius Matassov, Theresa E Latham, Ayuko Ota-Setlik, Michael A Egan

Lancet Infect Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis